Logo

Quanterix

Quanterix Q4 Revenues Down 15 Percent

The company posted revenues of $25.8 million for the quarter, down from $30.3 million in Q4 2021 and in line with the consensus Wall Street estimate.

People in the News at Quanterix, Arima Genomics, Theralink, Vizgen, DNAnexus, More

Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Jan. 9, 2023.

JP Morgan Healthcare Conference, Day 4: Singular Genomics, Quantum-Si, Quanterix

On the last day of the conference, Singular Genomics and Quantum-Si provided updates on their recently launched systems while Quanterix addressed its ongoing restructuring.

GenomeWeb Top 40 Down 3 Percent in December, Though More Resilient Than Broader Market

The Dow Jones Industrial Average was down 4 percent, while the Nasdaq fell 9 percent, and the Nasdaq Biotech Index was down 3 percent.

Proteomics Research Innovation Progressed in 2022 Despite Challenging Business Conditions
Premium

For proteomics firms, 2022 marked a reversal from an earlier boom, but the field pushed into emerging areas like single-cell, single-molecule, and spatial analyses.

Oct 3, 2022

GenomeWeb Top 40 Declines 9 Percent in September, Marking Second Consecutive Down Month

Sep 1, 2022

GenomeWeb Top 40 Down 11 Percent in August, Reversing Previous Month's Gains

Aug 15, 2022

Top Five Articles on GenomeWeb Last Week: Illumina, 10x Genomics, 23andMe, Quanterix, More

Aug 15, 2022

Canaccord Downgrades Quanterix From Buy to Hold

Aug 9, 2022

Quanterix Slashing Workforce by 25 Percent as It Refocuses Commercial Efforts
Premium

May 20, 2022

In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More

May 10, 2022

Quanterix Q1 Revenues up 9 Percent

Mar 4, 2022

People in the News: New Appointments at Seegene, Quanterix, Deepcell, More

Mar 1, 2022

Stocks of Omics Tools, MDx Firms Find More Stable Footing in February After Tough Start to Year

Mar 1, 2022

Quanterix Q4 Revenues Rise 16 Percent

Jan 28, 2022

Emerging Single-Molecule Proteomic Technologies May Grow Into Competitors for Quanterix
Premium

Jan 13, 2022

Quanterix Projects Q4 2021 Revenues of $29M to $31M

Nov 4, 2021

Quanterix Q3 Revenues Decline 12 Percent, Beat Wall Street Estimates

Aug 5, 2021

Quanterix Revenues Almost Double in Q2

Jun 15, 2021

Study Explores Usefulness of NfL as Biomarker Across Range of Neurological Conditions
Premium

May 21, 2021

People in the News: New Appointments at Illumina, Pacific Biosciences, Qiagen, Quanterix, More

May 5, 2021

Quanterix Q1 Revenues up 73 Percent

Apr 1, 2021

GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock

Mar 10, 2021

Investor Interest in Proteomics Rising on New, Improving Technologies
Premium

Mar 2, 2021

Quanterix Q4 Revenues Up 64 Percent

Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.